Showing results (141-150 of 175) with videos related to
Sort By:
Pageof 18
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 8, 2020
Evaluation of Guideline Adherence for Cardiac Catheterization in Patients With Presumed Obstructive Coronary Artery Disease in Germany (ENLIGHT-KHK) - A Multicentre, Prospective, Observational StudyYana Seleznova, Bastian Wein, Dirk Müller, et al.Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 23, 2017
[Report from an ongoing research project: The Cologne Research and Development Network (CoRe-Net) and the value-based approach to healthcare]Ute Karbach, Lena Ansmann, Nadine Scholten, et al.BMC Medical Informatics and Decision Making|June 6, 2021
Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-makingSibylle Kautz-Freimuth, Marcus Redaèlli, Kerstin Rhiem, et al.BMC Sports Science, Medicine & Rehabilitation|September 18, 2020
A lifestyle intervention during pregnancy to reduce obesity in early childhood: the study protocol of ADEBAR - a randomized controlled trialNina Ferrari, Laura Schmitz, Nikola Schmidt, et al.Frontiers in Oncology|October 10, 2022
Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastasesJulia Simões Corrêa Galendi, Sin Yuin Yeo, Holger Grüll, et al.Journal of Cancer Research and Clinical Oncology|September 9, 2025
DigiNet: Optimizing personalized care for patients with stage IV non-small cell lung cancer (NSCLC) through a digitally connected provider network-analysis plan of a prospective multicenter cohort trialAnika Kästner, Anna Kron, Leonie Eilers, et al.Leukemia & Lymphoma|November 21, 2015
Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemiaDirk Müller, Kirsten Fischer, Peter Kaiser, et al.Trials|March 12, 2024
Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trialChristoph Heinrich Lindemann, Volker Burst, Linus Alexander Völker, et al.Journal of Patient-Reported Outcomes|May 28, 2026
Implementation of patient-reported outcomes in personalized lung cancer care: a qualitative study from the perspective of patients and health care providersVanessa Mildenberger, Dusan Simic, Leonie Eilers, et al.BMJ Open|March 12, 2020
Evaluation of a complex integrated, cross-sectoral psycho-oncological care program (isPO): a mixed-methods study protocolImke Jenniches, Clarissa Lemmen, Jan Christopher Cwik, et al.Pageof 18